Literature DB >> 33879491

Role of masks, testing and contact tracing in preventing COVID-19 resurgences: a case study from New South Wales, Australia.

Robyn M Stuart1,2, Romesh G Abeysuriya2, Cliff C Kerr3,4, Dina Mistry3, Dan J Klein3, Richard T Gray5, Margaret Hellard2,6,7,8, Nick Scott2.   

Abstract

OBJECTIVES: The early stages of the COVID-19 pandemic illustrated that SARS-CoV-2, the virus that causes the disease, has the potential to spread exponentially. Therefore, as long as a substantial proportion of the population remains susceptible to infection, the potential for new epidemic waves persists even in settings with low numbers of active COVID-19 infections, unless sufficient countermeasures are in place. We aim to quantify vulnerability to resurgences in COVID-19 transmission under variations in the levels of testing, tracing and mask usage.
SETTING: The Australian state of New South Wales (NSW), a setting with prolonged low transmission, high mobility, non-universal mask usage and a well-functioning test-and-trace system. PARTICIPANTS: None (simulation study).
RESULTS: We find that the relative impact of masks is greatest when testing and tracing rates are lower and vice versa. Scenarios with very high testing rates (90% of people with symptoms, plus 90% of people with a known history of contact with a confirmed case) were estimated to lead to a robustly controlled epidemic. However, across comparable levels of mask uptake and contact tracing, the number of infections over this period was projected to be 2-3 times higher if the testing rate was 80% instead of 90%, 8-12 times higher if the testing rate was 65% or 30-50 times higher with a 50% testing rate. In reality, NSW diagnosed 254 locally acquired cases over this period, an outcome that had a moderate probability in the model (10%-18%) assuming low mask uptake (0%-25%), even in the presence of extremely high testing (90%) and near-perfect community contact tracing (75%-100%), and a considerably higher probability if testing or tracing were at lower levels.
CONCLUSIONS: Our work suggests that testing, tracing and masks can all be effective means of controlling transmission. A multifaceted strategy that combines all three, alongside continued hygiene and distancing protocols, is likely to be the most robust means of controlling transmission of SARS-CoV-2. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; health policy; public health

Year:  2021        PMID: 33879491     DOI: 10.1136/bmjopen-2020-045941

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  5 in total

1.  WHotLAMP: A simple, inexpensive, and sensitive molecular test for the detection of SARS-CoV-2 in saliva.

Authors:  David Ng; Ana Pinharanda; Merly C Vogt; Ashok Litwin-Kumar; Kyle Stearns; Urvashi Thopte; Enrico Cannavo; Armen Enikolopov; Felix Fiederling; Stylianos Kosmidis; Barbara Noro; Ines Rodrigues-Vaz; Hani Shayya; Peter Andolfatto; Darcy S Peterka; Tanya Tabachnik; Jeanine D'Armiento; Monica Goldklang; Andres Bendesky
Journal:  PLoS One       Date:  2021-09-16       Impact factor: 3.752

2.  Estimating and mitigating the risk of COVID-19 epidemic rebound associated with reopening of international borders in Vietnam: a modelling study.

Authors:  Quang D Pham; Robyn M Stuart; Thuong V Nguyen; Quang C Luong; Quang D Tran; Thai Q Pham; Lan T Phan; Tan Q Dang; Duong N Tran; Hung T Do; Dina Mistry; Daniel J Klein; Romesh G Abeysuriya; Assaf P Oron; Cliff C Kerr
Journal:  Lancet Glob Health       Date:  2021-04-12       Impact factor: 26.763

3.  Risk of sustained SARS-CoV-2 transmission in Queensland, Australia.

Authors:  Paula Sanz-Leon; Nathan J Stevenson; Robyn M Stuart; Romesh G Abeysuriya; James C Pang; Stephen B Lambert; Cliff C Kerr; James A Roberts
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.996

4.  Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2.

Authors:  Paula Sanz-Leon; Lachlan H W Hamilton; Sebastian J Raison; Anna J X Pan; Nathan J Stevenson; Robyn M Stuart; Romesh G Abeysuriya; Cliff C Kerr; Stephen B Lambert; James A Roberts
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2022-08-15       Impact factor: 4.019

5.  COVID-19 testing decisions and behaviours in two Australian cities.

Authors:  Penelope A Robinson; David C Levy; Claire Hooker; Ramon Z Shaban; Shizar Nahidi; Julie Leask; Kerrie E Wiley
Journal:  Health Promot J Austr       Date:  2022-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.